COVID-19 感染期间使用类固醇与高血糖——医生应该知道的。
Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.
机构信息
Diacon Hospital, Bangalore, India.
Jothydev's Diabetes Research Centers, Kerala, India.
出版信息
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102167. doi: 10.1016/j.dsx.2021.06.004. Epub 2021 Jun 10.
BACKGROUND AND AIMS
The COVID-19 pandemic continues to challenge us. Despite several strides in management, steroids remain the mainstay for treating moderate to severe disease and with it arises challenges such as hyperglycemia. The review aims to enhance awareness amongst physicians on steroid use and hyperglycemia.
METHODS
An advisory document describing various strategies for hyperglycemia management was prepared in the public interest by DiabetesIndia.
RESULTS
The review provides awareness on steroids and hyperglycemia, adverse outcomes of elevated blood glucose levels and, advice at the time of discharge.
CONCLUSIONS
The article emphasizes enhancing awareness on effective management of hyperglycemia during COVID-19.
背景与目的
COVID-19 大流行仍在给我们带来挑战。尽管在管理方面取得了一些进展，但类固醇仍然是治疗中重度疾病的主要方法，随之而来的是高血糖等挑战。本次综述旨在提高医生对类固醇使用和高血糖的认识。
方法
为了公众利益，DiabetesIndia 编写了一份关于高血糖管理各种策略的咨询文件。
结果
该综述提高了对类固醇和高血糖、血糖升高的不良后果以及出院时的建议的认识。
结论
本文强调了在 COVID-19 期间提高对高血糖有效管理的认识的重要性。
Zotero 插件